v3.26.1
Net Loss Per Share (Details) - shares
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted weighted-average shares outstanding (in shares) 3,359,745 2,387,582
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted weighted-average shares outstanding (in shares) 1,820,742 1,119,010
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted weighted-average shares outstanding (in shares) 1,399,851 1,268,571
Common stock issuable upon conversion of Series A Preferred Stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted weighted-average shares outstanding (in shares) 131,280 0
Common stock issuable upon exercise or conversion of the securities underlying the Agent Units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted weighted-average shares outstanding (in shares) 7,872 0